The pharma sector faces a critical challenge: bridging the widening digital divide. To keep pace with rapid technological advancements, companies need to break down silos and integrate their digital initiatives, ensuring a seamless and effective approach to innovation.

Ostro Co-Founder Chase Feiger, M.D. rightly points out, "The deepening digital disconnect is a threat to progress. A unified digital strategy not only enhances operational efficiency but also drives better patient outcomes." It’s time for the industry to rethink its approach.

Read more in the full MM+M article